Obesity/Weight Loss Pharmacotherapy Colemen Flashcards

1
Q

who are candidates for pharmacotherapy?

A

BMI > or = to 30 OR BMI > or = to 27 with other risk factors (HTN, diabetes, dyslipidemia, etc) AND did not lose weight OR maintain weight with comprehensive lifestyle intervention (< 5% loss in 3-6 months of actively trying)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

initial goal for reduction of body weight: ___ to ___ % of initial weight over ___ months

A

5 to 10%; 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

after initiating pharmacotherapy, when should we follow up?

A

-every month for the first 3 months of therapy
-after first 3 months, follow up every 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what class of drugs are short-term pharmacotherapy options?

a. lipase inhibitors
b. GLP-1 agonists
c. CNS stimulants
d. melanocortin receptor agonist

A

c. CNS stimulants

(ex. phentermine, phendimetrazine, benzphetamine, diethylpropion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MOA of CNS stimulants: inc conc of __________ to stimulate receptors in hypothalamus, resulting in appetite suppression

A

norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Orlistat (Xenical or Alli) is in what drug class?

a. lipase inhibitors
b. sympathomimetic/anticonvulsant
c. GLP-1 agonists
d. melanocortin receptor agonist

A

a. lipase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

is Xenical (Orlistat) Rx or OTC?

A

Rx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

is Alli (Orlistat) Rx or OTC?

A

OTC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MOA of Orlistat (3 things)

A

-reversibly inhibits gastric and pancreatic lipases
-dec absorption of dietary fats by ~30%
-minimally absorbed and does not work systemically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

when should Xenical or Alli (Orlistat) be taken?

A

within 1 hour of eating a fat-containing meal

(omit dose if meal is missed or does not contain fat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Xenical is approved for what age?

A

12 and up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Alli is approved for what age?

A

18 and up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Orlistat is suggested for pts with what disease?

A

CV disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

common adverse effects of Orlistat (2)

A

-GI
-dec absorption of fat sol. vitamins from diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CIs of Orlistat (3 of them)

A

-pregnancy
-chronic malabsorption syndrome
-cholestasis (slow/blocked bile flow)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Qsymia is a combo of what 2 drugs?

A

phentermine and topiramate ER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what class is Qsymia in?

a. lipase inhibitors
b. sympathomimetic and anticonvulsant
c. opiod antag and dopamine/norepi reuptake inhibitor
d. melanocortin receptor agonist

A

b. sympathomimetic and anticonvulsant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what drug class is Contrave in?

a. lipase inhibitors
b. sympathomimetic and anticonvulsant
c. opiod antag and dopamine/norepi reuptake inhibitor
d. melanocortin receptor agonist

A

c. opiod antag and dopamine/norepi reuptake inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what two drugs make up Contrave?

A

naltrexone and bupropion XR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

MOA of phentermine (sympathomimetic amine)

A

-stimulates hypothalamus to release norepi, which stimulates the satiety center, decreasing appetite

20
Q

Qsymia increases what 3 neurotransmitters to dec appetite and cravings?

A

-norepinephrine
-dopamine
-serotonin

21
Q

what schedule controlled substance is Qsymia?

22
Q

if you are on max dose of Qsymia (15/92 mg) and 5% of baseline weight has not been lost after 12 weeks, what should you do?

A

gradually discontinue

23
Q

do not exceed phentermine/topiramate ER 7.5/46 gm once daily with CrCl < ___ mL/min

24
for moderate hepatic impairment, do not exceed what dose of Qsymia once daily?
7.5/46 mg
25
true or false: Qsymia is not recommended in dialysis or severe hepatic impairment patients
true
26
what time of day should Qsymia be taken?
morning to prevent insomnia
27
how should Qsymia be gradually decreased?
take every other day for at least one week prior to discontinuing
28
true or false: Qsymia is allowed for pregnant patients
false (need to do REMS program due to teratogenicity)
29
dosing schedule for naltrexone/bupropion ER (Contrave)
-supplied as naltrexone 8 mg/bupropion 90 mg ER tablets -week 1 -> 1 tablet once daily in morning -week 2 -> 1 tablet BID -week 3 -> 2 tablets in morning and 1 in evening -week 4 -> 2 tablets BID
30
max daily dose of Contrave
4 tablets (naltrexone 32 mg/bupropion 360 mg)
31
Contrave can cause an inc in _____ _____
blood pressure (so wouldn't be appropriate for pt with HTN)
32
true or false: Contrave should be taken with a high fat meal
false
33
boxed warning for Contrave
suicidality
34
true or false: Contrave is CI in pregnancy
true
35
MOA of liraglutide (Saxenda) and semaglutide (Wegovy)
GLP-1 receptor agonist
36
boxed warning of Saxenda and Wegovy
thyroid C-cell tumors
37
liraglutide (Saxenda) dosing
-start at 0.6 mg daily x 1 week, inc by 0.6 mg/day every week -target dose: 3 mg/day
38
when to discontinue Saxenda
if 5% weight loss not achieved after 16 weeks of therapy
39
Wegovy dosing (probably don't need to know this)
-start at 0.25 mg once weekly for 1 month -month 2: 0.5 mg each week -month 3: 1 mg each week -month 4: 1.7 mg each week -month 5 and onward: 2.4 mg each week (target dose is 2.4 mg once weekly)
40
which drug is a melanocortin receptor antagonist?
setmelanotide (Imcivree)
41
setmelanotide (Imcivree) MOA
-melanocortin-4 (MC4) receptor agonist (these receptors in brain are involved in regulation of hunger, satiety, and energy expenditure)
42
which drug is used for pts with a genetic disorder in POMC, PCSK1, and LEPR genes? a. Wegovy b. Contrave c. Qsymia d. Imcivree
d. Imcivree (setmelanotide) (deficiency in these genes impair MC4 pathway)
43
setmelanotide (Imcivree) dosing for ages 12 and up
start at 2 mg once daily for 2 weeks, target dose is 3 mg once daily
44
monitoring parameters for alternative therapies
-recommended closely monitoring during initial 6 months of treatment -follow up every 4 weeks
45
what drug is approved for patients > 6 years of age with Bardet-Biedl syndrome (BBS), or POMC, PCSK1, or LEPR deficiency?
Imcivree (setmelanotide)
46
which drug should not be used in pts with hypertension? a. stimulants b. Orlistat c. Saxenda d. Contrave
d. Contrave
47
what are the 4 CNS stimulants? (slide 8)
-phentermine (Adipex-P or Lomaira) -phendimetrazine -benzphetamine (Regimax) -diethylpropion